Lataa...
Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia
Patients with B cell precursor acute lymphoblastic leukemia (BPL) respond well to chemotherapy at initial diagnosis; however, therapeutic options are limited for individuals with BPL who relapse. Almost all BPL cells express CD19, and we recently cloned the gene encoding a natural ligand of the huma...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362237/ https://ncbi.nlm.nih.gov/pubmed/25621496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI76610 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|